- Grupo Sura reported a net income of COP 652.18 billion for the third quarter of 2024.
- This marks a 99% increase in net income compared to the same period last year.
- The net income for the third quarter of 2023 was COP 327.92 billion.
- Net premiums written by Grupo Sura for the third quarter of 2024 were COP 6.38 trillion.
- There was a 21% decline in net premiums written compared to the previous year.
- Analyst ratings for Grupo Sura include 0 buys, 3 holds, and 2 sells.
“`
A look at Grupo de Inversiones Suramericana Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Grupo de Inversiones Suramericana has a promising long-term outlook as indicated by its strong Smart Scores across various factors. With a high Growth score of 5, the company is positioned for considerable expansion and development in the future. Additionally, its Momentum score of 5 suggests a positive trend in performance that is likely to continue.
While the Dividend score is moderate at 2, indicating room for improvement in this area, Grupo de Inversiones Suramericana excels in Value and Resilience with scores of 4, showcasing its strong underlying financials and ability to withstand market challenges. Overall, the company’s strategic investments in key sectors across the Americas bode well for its sustained growth and stability in the long run.
### Summary: Grupo de Inversiones Suramericana holds investments in leading Colombian companies as well as other important stakes in other countries of the Americas. This portfolio is mainly concentrated in strategic investments in the financial, insurance and social security sectors and is complemented by other investments in services, food, and cement sectors amongst others. ###
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
